SCHEMBL27204696

SCHEMBL27204696

NC(CO)Cc1nc(-c2ccc(Oc3ccc(Cl)cn3)cc2)no1

nearest known ligand 0.70

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LTA4H P09960 3/20 0.70
▸ KCNH2 Q12809 1/20 0.69
▸ SCN5A Q14524 2/20 0.52
▸ SCN10A Q9Y5Y9 2/20 0.52
▸ NOTUM Q6P988 2/20 0.46
▸ MAPT P10636 2/20 0.45
▸ TSHR P16473 3/20 0.43
▸ MAPK1 P28482 2/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43
▸ FFAR1 O14842 1/20 0.43
▸ SCN9A Q15858 3/20 0.43
▸ SIRT2 Q8IXJ6 1/20 0.43
▸ FPR2 P25090 1/20 0.43
▸ NPC1 O15118 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27171426 1.00 LTA4H (0.70) LTA4HKCNH2SCN5ASCN10ANOTUM
SCHEMBL27204649 0.88 LTA4H (0.58) LTA4HKCNH2SCN5ASCN10ANOTUM
SCHEMBL24665357 0.88 LTA4H (0.58) LTA4HKCNH2SCN5ASCN10ANOTUM
SCHEMBL27204783 0.86 LTA4H (0.68) LTA4HKCNH2SCN5ASCN10ANOTUM
SCHEMBL27171420 0.86 LTA4H (0.68) LTA4HKCNH2SCN5ASCN10ANOTUM
SCHEMBL27171402 0.85 LTA4H (0.67) LTA4HKCNH2FFAR1SCN9AFPR2
SCHEMBL27204647 0.85 LTA4H (0.67) LTA4HKCNH2FFAR1SCN9AFPR2
SCHEMBL29123608 0.84 LTA4H (0.52) LTA4HKCNH2SCN5ASCN10ANOTUM
SCHEMBL29123605 0.84 LTA4H (0.52) LTA4HKCNH2SCN5ASCN10ANOTUM
SCHEMBL27204884 0.82 LTA4H (0.50) LTA4HKCNH2NOTUMMAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117015537-A Heteroaryl aminopropanol derivatives as inhibitors of LTA4H 诺华股份有限公司 2023-11-07 — — CN claimed
US-11932630-B2 Heteroaryl aminopropanol derivatives NOVARTIS AG (CH) 2024-03-19 — — US disclosed
CN-117015537-A Heteroaryl aminopropanol derivatives as inhibitors of LTA4H 诺华股份有限公司 2023-11-07 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11932630-B2 Heteroaryl aminopropanol derivatives CYP3A43, CYP11B2, ADRB3 LTA4H 1006/4885KCNH2 1449/4885SCN5A 271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback